Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price dropped 5.5% during trading on Tuesday . The stock traded as low as $7.9152 and last traded at $7.9152. Approximately 500 shares were traded during trading, a decline of 35% from the average daily volume of 771 shares. The stock had previously closed at $8.3750.
Oxford BioMedica Trading Down 5.5%
The company has a fifty day moving average of $8.13 and a 200 day moving average of $9.03.
About Oxford BioMedica
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Featured Stories
- Five stocks we like better than Oxford BioMedica
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
